Baird Medical Investment Holdings (BDMDW) Raw Materials (2023 - 2025)

Baird Medical Investment Holdings has reported Raw Materials for 3 years, with the latest figure at $374738.0 in Q4 2025.

• For the quarter ending Q4 2025, Raw Materials rose 7.4% year-over-year to $374738.0; the trailing twelve-month figure through Dec 2025 stood at $374738.0 (up 7.4% YoY), and the FY2025 full-year result was $374738.0, up 7.4% from the prior year.
• Raw Materials for Q4 2025 stood at $374738.0, up from $348910.0 in the prior quarter.
• The five-year high for Raw Materials was $516346.0 in Q4 2023, with the low at $348910.0 in Q4 2024.
• Average Raw Materials over 3 years is $413331.3, with a median of $374738.0 recorded in 2025.
• Year-over-year, Raw Materials sank 32.43% in 2024 and gained 7.4% in 2025.
• Tracing BDMDW's Raw Materials over 3 years: stood at $516346.0 in 2023, then plunged by 32.43% to $348910.0 in 2024, then climbed by 7.4% to $374738.0 in 2025.
• The last three Raw Materials figures came in at $374738.0 (Q4 2025), $348910.0 (Q4 2024), and $516346.0 (Q4 2023), per Business Quant data.

Peer Comparison